Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Amortizatization of Intangibles (2021 - 2025)

Historic Amortizatization of Intangibles for Pliant Therapeutics (PLRX) over the last 5 years, with Q3 2025 value amounting to $821000.0.

  • Pliant Therapeutics' Amortizatization of Intangibles rose 148.33% to $821000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 16287.37%. This contributed to the annual value of $3.5 million for FY2024, which is 4439.33% up from last year.
  • As of Q3 2025, Pliant Therapeutics' Amortizatization of Intangibles stood at $821000.0, which was up 148.33% from $815000.0 recorded in Q2 2025.
  • In the past 5 years, Pliant Therapeutics' Amortizatization of Intangibles registered a high of $3.9 million during Q2 2023, and its lowest value of -$7.8 million during Q4 2023.
  • Its 5-year average for Amortizatization of Intangibles is $621947.4, with a median of $809000.0 in 2024.
  • Over the last 5 years, Pliant Therapeutics' Amortizatization of Intangibles had its largest YoY gain of 105000.0% in 2023, and its largest YoY loss of 140852.84% in 2023.
  • Pliant Therapeutics' Amortizatization of Intangibles (Quarter) stood at $806000.0 in 2021, then fell by 25.81% to $598000.0 in 2022, then crashed by 1408.53% to -$7.8 million in 2023, then skyrocketed by 110.36% to $811000.0 in 2024, then rose by 1.23% to $821000.0 in 2025.
  • Its last three reported values are $821000.0 in Q3 2025, $815000.0 for Q2 2025, and $813000.0 during Q1 2025.